A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.
about
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A pharmacoepidemiological stud ...... ogy of the MONITOR-CKD5 study.
@en
A pharmacoepidemiological stud ...... ogy of the MONITOR-CKD5 study.
@nl
type
label
A pharmacoepidemiological stud ...... ogy of the MONITOR-CKD5 study.
@en
A pharmacoepidemiological stud ...... ogy of the MONITOR-CKD5 study.
@nl
prefLabel
A pharmacoepidemiological stud ...... ogy of the MONITOR-CKD5 study.
@en
A pharmacoepidemiological stud ...... ogy of the MONITOR-CKD5 study.
@nl
P2093
P2860
P50
P1476
A pharmacoepidemiological stud ...... logy of the MONITOR-CKD5 study
@en
P2093
Adrian Covic
David Goldsmith
Frank Dellanna
Gérard London
Ivo Abraham
Johannes Mann
Karen Macdonald
Matthew Turner
Michael Muenzberg
Philippe Zaoui
P2860
P2888
P304
P356
10.1007/S11739-011-0622-7
P577
2011-05-18T00:00:00Z